Table 3—

Surgery in invasive pulmonary aspergillosis (IPA): indication and risks

Indication for SurgeryLocaliszed or multilocular IPA
Early stage IPA
Failure of antifungal therapy
Planned immunosuppression, e.g. HDC or SCT
Haemoptysis
Perioperative mortality14%(24 of 165 patients)
Postoperative complications7%(12 of 165 patients)
(nonfatal)
Recurrent mould infection16%(27 of 165 patients)
Fungal relapse post SCT8%(3 of 35 patients)
  • HDC: high dose chemotherapy

  • SCT: stem cell transplantation